Rate My Professor Michael Stitely

His academic interests and research focus on key areas within obstetrics and gynaecology, including postpartum haemorrhage management, antiepileptic drug exposure during pregnancy and child developmental outcomes, pelvic organ prolapse, urinary incontinence, labour induction methods, and access to first trimester abortion services in New Zealand. Stitely has contributed to innovative solutions, such as co-developing a 3D-printed device to simplify intrauterine device insertion, which won the University of Otago's 2019 Proof of Concept competition. Notable publications co-authored by him include "Antiepileptic drug exposure in pregnancy and neonatal bleeding risk" (2018), "Developmental outcomes at age four following maternal antiepileptic drug use" (2019), "The Before School Check (B4SC): reporting outcomes and referral rates for all New Zealand children" (2019), "Outpatient balloon catheter vs inpatient prostaglandin for induction of labour (OBLIGE): a randomised controlled trial" (2020), "What does abortion law reform mean for primary care practitioners in New Zealand?" (2021), "Rates of Māori women receiving surgical treatment for urinary incontinence and pelvic organ prolapse in Southern District Health Board" (2021), "Outpatient balloon versus inpatient prostaglandin for induction of labor: a randomized trial" (2023), "The first trimester abortion journey Aotearoa: health practitioners' perspectives" (2024), and "The journey of people accessing first trimester abortion in Aotearoa New Zealand: health consumers' perspectives" (2025). With over 880 citations across 55 publications, his work influences clinical practice and policy in women's health.